These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9248702)

  • 1. Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor.
    Slieker LJ; Brooke GS; DiMarchi RD; Flora DB; Green LK; Hoffmann JA; Long HB; Fan L; Shields JE; Sundell KL; Surface PL; Chance RE
    Diabetologia; 1997 Jul; 40 Suppl 2():S54-61. PubMed ID: 9248702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
    Cara JF; Nakagawa SH; Tager HS
    Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
    Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
    Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
    Hodgson DR; May FE; Westley BR
    Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor.
    Gauguin L; Klaproth B; Sajid W; Andersen AS; McNeil KA; Forbes BE; De Meyts P
    J Biol Chem; 2008 Feb; 283(5):2604-13. PubMed ID: 18048361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity.
    Kohn WD; Micanovic R; Myers SL; Vick AM; Kahl SD; Zhang L; Strifler BA; Li S; Shang J; Beals JM; Mayer JP; DiMarchi RD
    Peptides; 2007 Apr; 28(4):935-48. PubMed ID: 17328992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alanine scanning of a putative receptor binding surface of insulin-like growth factor-I.
    Gauguin L; Delaine C; Alvino CL; McNeil KA; Wallace JC; Forbes BE; De Meyts P
    J Biol Chem; 2008 Jul; 283(30):20821-9. PubMed ID: 18502759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective response to insulin versus insulin-like growth factor-I and -II and up-regulation of insulin receptor splice variant B in the differentiated mouse mammary epithelium.
    Berlato C; Doppler W
    Endocrinology; 2009 Jun; 150(6):2924-33. PubMed ID: 19246539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of common ligand binding determinants of the insulin and insulin-like growth factor 1 receptors. Insights into mechanisms of ligand binding.
    Mynarcik DC; Williams PF; Schaffer L; Yu GQ; Whittaker J
    J Biol Chem; 1997 Jul; 272(30):18650-5. PubMed ID: 9228034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analogs of human insulin-like growth factor I with reduced affinity for serum binding proteins and the type 2 insulin-like growth factor receptor.
    Bayne ML; Applebaum J; Chicchi GG; Hayes NS; Green BG; Cascieri MA
    J Biol Chem; 1988 May; 263(13):6233-9. PubMed ID: 2966152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth promoting and metabolic activity of the human insulin analogue [GlyA21,ArgB31,ArgB32]insulin (HOE 901) in muscle cells.
    Bähr M; Kolter T; Seipke G; Eckel J
    Eur J Pharmacol; 1997 Feb; 320(2-3):259-65. PubMed ID: 9059862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding.
    Chrudinová M; Žáková L; Marek A; Socha O; Buděšínský M; Hubálek M; Pícha J; Macháčková K; Jiráček J; Selicharová I
    J Biol Chem; 2018 Oct; 293(43):16818-16829. PubMed ID: 30213860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor.
    Kristensen C; Andersen AS; Hach M; Wiberg FC; Schäffer L; Kjeldsen T
    Biochem J; 1995 Feb; 305 ( Pt 3)(Pt 3):981-6. PubMed ID: 7848300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutants of human insulin-like growth factor I with reduced affinity for the type 1 insulin-like growth factor receptor.
    Cascieri MA; Chicchi GG; Applebaum J; Hayes NS; Green BG; Bayne ML
    Biochemistry; 1988 May; 27(9):3229-33. PubMed ID: 2839228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.
    Oh Y; Beukers MW; Pham HM; Smanik PA; Smith MC; Rosenfeld RG
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications.
    Zhao M; Wan ZL; Whittaker L; Xu B; Phillips NB; Katsoyannis PG; Ismail-Beigi F; Whittaker J; Weiss MA
    J Biol Chem; 2009 Nov; 284(46):32178-87. PubMed ID: 19773552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues.
    Glendorf T; Knudsen L; Stidsen CE; Hansen BF; Hegelund AC; Sørensen AR; Nishimura E; Kjeldsen T
    PLoS One; 2012; 7(2):e29198. PubMed ID: 22383948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions.
    Hashimoto R; Fujiwara H; Higashihashi N; Enjoh-Kimura T; Terasawa H; Fujita-Yamaguchi Y; Inagaki F; Perdue JF; Sakano K
    J Biol Chem; 1995 Jul; 270(30):18013-8. PubMed ID: 7629109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor.
    Milazzo G; Sciacca L; Papa V; Goldfine ID; Vigneri R
    Mol Carcinog; 1997 Jan; 18(1):19-25. PubMed ID: 9022809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir.
    Varewijck AJ; Goudzwaard JA; Brugts MP; Lamberts SW; Hofland LJ; Janssen JA
    Growth Horm IGF Res; 2010 Dec; 20(6):427-31. PubMed ID: 21055982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.